RECRUITINGOBSERVATIONAL
Magnetic Resonance Imaging In Acute ST-Elevation Myocardial Infarction
Clinical Relevance of Magnetic Resonance Imaging in Acute ST-Elevation Myocardial Infarction
About This Trial
Cardiovascular magnetic resonance imaging enables comprehensive assessment of cardiovascular function, morphology and pathology. The investigators aim to evaluate the nature and clinical significance of magnetic resonance imaging parameters in patients presenting with first acute ST-elevation myocardial infarction.
Who May Be Eligible (Plain English)
Who May Qualify:
- First ST-elevation myocardial infarction according to the European Society of Cardiology/American College of Cardiology committee criteria
- Primary percutaneous coronary intervention within 24 hours after symptom onset
Who Should NOT Join This Trial:
- Age \< 18 years
- Any history of a previous myocardial infarction or coronary intervention
- Clinically unstable patients (Killip class \>2)
- Renal failure (estimated glomerular filtration rate \< 30 ml/min/1.73 m2)
- Contraindications to cardiac magnetic resonance imaging (pacemaker, cerebral aneurysm clip, orbital foreign body, known or suggested contrast allergy to gadolinium, claustrophobia)
- Inability to provide willing to sign a consent form
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion criteria:
* First ST-elevation myocardial infarction according to the European Society of Cardiology/American College of Cardiology committee criteria
* Primary percutaneous coronary intervention within 24 hours after symptom onset
Exclusion criteria:
* Age \< 18 years
* Any history of a previous myocardial infarction or coronary intervention
* Clinically unstable patients (Killip class \>2)
* Renal failure (estimated glomerular filtration rate \< 30 ml/min/1.73 m2)
* Contraindications to cardiac magnetic resonance imaging (pacemaker, cerebral aneurysm clip, orbital foreign body, known or suggested contrast allergy to gadolinium, claustrophobia)
* Inability to provide informed consent
Treatments Being Tested
DIAGNOSTIC_TEST
Cardiovascular Magnetic Resonance Imaging
Cardiovascular magnetic resonance imaging will be performed within the first week after ST-elevation myocardial infarction and in a defined subgroup 4 months, 12 months and 10 years thereafter.
Locations (2)
University Hospital for Internal Medicine III (Cardiology and Angiology)
Innsbruck, Austria
University Hospital for Radiology
Innsbruck, Austria